Journal of Clinical and Cellular Immunology
Open Access

A Brief Note on Humoral Immune

Marion Pepper^{* *}Correspondence: Marion Pepper, Department of Immunology, University of Washington School of Medicine, Seattle, USA, Email:

Author info »

Description

The humoral immune response is needed for optimal vaccination methods against a variety of pathogens, including viruses and harmful bacteria. Neutralizing antibodies created during infection with highly evolving viruses like HIV, HCV, and influenza have also influenced contemporary vaccine design efforts. Both proliferative and differentiation processes are activated by the attachment of the B cell receptor (BCR) to a cognate antigen in the context of several other signals. These mechanisms result in increased populations of both early effector cells capable of secreting large amounts of antibody and long-lived B cells capable of protecting against secondary infections. We have made significant progress in our understanding of the molecular regulation of the development, function, and maintenance of humoral immune responses elicited by immunizations in recent years. We now have a better knowledge of the crucial connections between CD4⁺ T cells and B cells, as well as the main transcriptional regulators involved in germinal centre (GC) responses and the many populations of memory cells that emerge from the GC (both LLPCs and MBCs). We now need to understand how specific B cell populations can be best protective against various microbial diseases, taking into consideration unique inflammatory signatures, antigen loads, tropisms, or immune evasion mechanisms, in order to develop superior vaccines. We believe that over time, the evolution of host-pathogen interactions has resulted in more variation in the genesis and function of humoral immune responses than protein immunisation models have revealed. In this review, recent research show both common pathways shared by infection-specific humoral responses and unique aspects of pathogen-specific responses to overcome immune evasion techniques. This analysis will only cover B2 B cells because innate-like CD5⁺ B1 B-cells are not thought to form memory and their involvement in infection has lately been widely studied [1].

Based on their activation requirements, phenotypic, and location, B2 B cells can be split into sub-populations. The innate-like CD21⁺ marginal zones (MZ) B-cells, which are largely found in the splenic MZ, are the first B2 B cells to respond to infection. The MZ divides the follicle from the red pulp, creating a unique habitat for resident lymphocytes to collect blood antigens. B lymphocytes in the marginal zone have been demonstrated to be important early responders to infections caused by bacteria, viruses, and parasites. MZ B cells can also respond to antigen in a T cell-independent way, producing antibodies quickly and presenting captured antigens to CD4⁺ T cells [2]. MZ B cells have also been demonstrated to migrate into the B cell follicle after activation, where they can transfer antigen to follicular dendritic cells and aid follicular B cell activation. Follicular B cells found in follicles of the spleen and lymph nodes require more time and signals to differentiate. Follicular B-cells differentiate into plasma blasts or GC B cells in a Tdependent way. Plasma blasts are short-lived effector cells that release antibodies that are essential for the control of an infection. When cells enter the GC, mutations in their BCRs are evaluated against antigen presented on follicular dendritic cells, resulting in BCRs that are more diverse and have a higher affinity [3]. Germinal center-derived memory cells can survive in the bone marrow and spleen as long-lived, quiescent MBCs that are nevertheless responsive to reinvading infections, or as sessile long-lived plasma cells (LLPCs) [4]. LLPCs release antibodies without further antigenic stimulation, but due to their low BCR levels, they are unlikely to respond to a subsequent infection [5].

Conclusion

The ongoing co-evolution of pathogens and host immune responses has resulted in important diversity that is linked to both pathogen and host survival. While some reactions may be beneficial to certain infections, they can also be harmful to others. To develop more effective vaccine tactics, a better understanding of the function and production of varied humoral immune responses to specific microbial infections is essential. This broader view of humoral immunity could discover B cell tactics that aren't induced by present protein vaccination methods. New analytical methodologies, such as tools to analyze small populations of polyclonal, antigen-specific B cells, better DNA-sequencing, and single cell RNA seq platforms, have ushered in a new era of B cell immunology understanding.

References

1. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007; 357(19):1903–1915.

   [Crossref] [Google Scholar] [PubMed]

2. Burton DR, Hangartner L. Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design. Annu Rev Immunol. 2016; 34(4):635–659.

   [Crossref] [Google Scholar] [PubMed]

3.  Ball JK, Tarr AW, McKeating JA.The past, present and future of neutralizing antibodies for hepatitis C virus. Antiviral Res. 2014;105(4):100–111.

   [Crossref] [Google Scholar] [PubMed]

4.  Joyce MG, Wheatley AK, Thomas PV, Chuang GY, Soto C, Bailer RT, et al. Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza a Viruses. Cell. 2016;166(3):609–623.

   [Crossref] [Google Scholar] [PubMed]

5. Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM. The generation of antibody-secreting plasma cells. Nat Rev Immunol. 2015;15(3):160–171.

   [Crossref] [Google Scholar] [PubMed].